Eric Hedrick - 25 Feb 2022 Form 4 Insider Report for EQRx, Inc.

Role
Chief Physician Executive
Signature
/s/ William Collins, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
25 Feb 2022
Net transactions value
$0
Form type
4
Filing time
01 Mar 2022, 16:31:30 UTC
Previous filing
21 Dec 2021
Next filing
04 Jan 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EQRX Stock Option (Right to Buy) Award $0 +505,051 $0.000000 505,051 25 Feb 2022 Common Stock 505,051 $3.03 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying this option vest and become exercisable in 48 equal monthly installments commencing February 1, 2022, subject to the Reporting Person's continuous service as of each vesting date.